HLRCC‐associated kidney cancers were initially recognized by their unique histologic features; however, a spectrum of growth patterns has been demonstrated and recent classifications have recognized FH deficiency as a distinct entity. The gene discussed is FH; the disease is hereditary leiomyomatosis and renal cell cancer.